GSK, MMV announce launch of new single─dose radical cure medicine to prevent the relapse of Plasmodium vivax malaria in ...
GSK plc and Medicines for Malaria Venture (MMV) announce that the first single-dose medicine for the prevention of relapse of Plasmodium vivax (P. vivax) malaria – tafenoquine, co-administered with chloroquine for radical cure, has now been launched in …